IFN-γ induces cysteinyl leukotriene receptor 2 expression and enhances the responsiveness of human endothelial cells to cysteinyl leukotrienes

Journal of Immunology

Volumn 178, Issue 8, 2007, Pages 5262-5270

  Woszczek, Grzegorz ^a   Chen, Li Yuan ^a   Nagineni, Sahrudaya ^a   Alsaaty, Sara ^a   Harry, Anya ^a   Logun, Carolea ^a   Pawliczak, Rafal ^a,b   Shelhamer, James H ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYSTEINYL LEUKOTRIENE RECEPTOR 2; EARLY GROWTH RESPONSE FACTOR 1; EARLY GROWTH RESPONSE FACTOR 2; EARLY GROWTH RESPONSE FACTOR 3; GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; INOSITOL 1,4,5 TRISPHOSPHATE; JANUS KINASE; JANUS KINASE 2; JANUS KINASE 2 INHIBITOR; LEUKOTRIENE RECEPTOR; MESSENGER RNA; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PEPTIDOLEUKOTRIENE; PHOSPHOLIPASE C; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM SIGNALING; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; CYSLTR2 GENE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; EXON; GENE; GENE STRUCTURE; HALF LIFE TIME; HUMAN; HUMAN CELL; INFLAMMATION; INNATE IMMUNITY; MOLECULAR CLONING; MONOCYTE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 34247127085     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.8.5262     Document Type: Article

References (32)

1. Kanaoka, Y., and J. A. Boyce. 2004. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J. Immunol. 173: 1503-1510.
2. Peters-Golden, M., C. Canetti, P. Mancuso, and M. J. Coffey. 2005. Leukotrienes: underappreciated mediators of innate immune responses. J. Immunol. 174: 589-594.
3. Lynch, K. R., G. P. O'Neill, Q. Liu, D. S. Im, N. Sawyer, K. M. Metters, N. Coulombe, M. Abramovitz, D. J. Figueroa, Z. Zeng, et al. 1999. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399: 789-793.
4. Heise, C. E., B. F. O'Dowd, D. J. Figueroa, N. Sawyer, T. Nguyen, D. S. Im, R. Stocco, J. N. Bellefeuille, M. Abramovitz, R. Cheng, et al. 2000. Characterization of the human cysteinyl leukotriene 2 receptor. J. Biol. Chem. 275: 30531-30536.
5. Nothacker, H. P., Z. Wang, Y. Zhu, R. K. Reinscheid, S. H. Lin, and O. Civelli. 2000. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist. Mol. Pharmacol. 58: 1601-1608.
6. Sarau, H. M., R. S. Ames, J. Chambers, C. Ellis, N. Elshourbagy, J. J. Foley, D. B. Schmidt, R. M. Muccitelli, O. Jenkins, P. R. Murdock, et al. 1999. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. Mol. Pharmacol. 56: 657-663.
7. 2 receptor. Biochem. Biophys. Res. Commun. 274: 316-322.
8. Lotzer, K., R. Spanbroek, M. Hildner, A. Urbach, R. Heller, E. Bretschneider, H. Galczenski, J. F. Evans, and A. J. Habenicht. 2003. Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 23: e32-e36.
9. Sjostrom, M., A. S. Johansson, O. Schroder, H. Qiu, J. Palmblad, and J. Z. Haeggstrom. 2003. Dominant expression of the CysLT2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells. Arterioscler. Thromb. Vasc. Biol. 23: e37-e41.
10. Pedersen, K. E., B. S. Bochner, and B. J. Undem. 1997. Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism. J. Pharmacol. Exp. Ther. 281: 655-662.
11. Datta, Y. H., M. Romano, B. C. Jacobson, D. E. Golan, C. N. Serhan, and B. M. Ewenstein. 1995. Peptido-leukotrienes are potent agonists of von Wille-brand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells. Circulation 92: 3304-3311.
12. Hui, Y., Y. Cheng, I. Smalera, W. Jian, L. Goldhahn, G. A. Fitzgerald, and C. D. Funk. 2004. Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure. Circulation 110: 3360-3366.
13. Dahlen, S. E., J. Bjork, P. Hedqvist, K. E. Arfors, S. Hammarstrom, J. A. Lindgren, and B. Samuelsson. 1981. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc. Natl. Acad. Sci. USA 78: 3887-3891.
14. Lotzer, K., C. D. Funk, and A. J. Habenicht. 2005. The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis. Biochim. Biophys. Acta 1736: 30-37.
15. Zhao, L., M. P. Moos, R. Grabner, F. Pedrono, J. Fan, B. Kaiser, N. John, S. Schmidt, R. Spanbroek, K. Lotzer, et al. 2004. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat. Med. 10: 966-973.
16. Young, J. L., P. Libby, and U. Schonbeck. 2002. Cytokines in the pathogenesis of atherosclerosis. Thromb. Haemostasis 88: 554-567.
17. Harvey, E. J., and D. P. Ramji. 2005. Interferon-γ and atherosclerosis: pro- or anti-atherogenic? Cardiovasc. Res. 67: 11-20.
18. Nakai, Y., K. Iwabuchi, S. Fujii, N. Ishimori, N. Dashtsoodol, K. Watano, T. Mishima, C. Iwabuchi, S. Tanaka, S. S. Bezbradica, et al. 2004. Natural killer T cells accelerate atherogenesis in mice. Blood 104: 2051-2059.
19. Walter, M. J., D. C. Look, R. M. Tidwell, W. T. Roswit, and M. J. Holtzman. 1997. Targeted inhibition of Interferon-γ-dependent intercellular adhesion molecule-1 (ICAM-1) expression using dominant-negative Stat1. J. Biol. Chem. 272: 28582-28589.
20. Woszczek, G., R. Pawliczak, H. Y. Qi, S. Nagineni, S. Alsaaty, C. Logun, and J. H. Shelhamer. 2005. Functional characterization of human cysteinyl leukotriene 1 receptor gene structure. J. Immunol. 175: 5152-5159.
21. Schroder, K., P. J. Hertzog, T. Ravasi, and D. A. Hume. 2004. Interferon-γ: an overview of signals, mechanisms and functions. J. Leukocyte Biol. 75: 163-189.
22. Forsythe, S. M., P. C. Kogut, J. F. McConville, Y. Fu, J. A. McCauley, A. J. Halayko, H. W. Liu, A. Kao, D. J. Fernandes, S. Bellam, et al. 2002. Structure and transcription of the human m3 muscarinic receptor gene. Am. J. Respir. Cell Mol. Biol. 26: 298-305.
23. Swan, C., S. A. Richards, N. P. Duroudier, I. Sayers, and I. P. Hall. 2006. Alternative promoter use and splice variation in the human histamine H1 receptor gene. Am. J. Respir. Cell Mol. Biol. 35: 118-126.
24. Fukai, H., Y. Ogasawara, O. Migita, M. Koga, K. Ichikawa, M. Shibasaki, T. Arinami, and E. Noguchi. 2004. Association between a polymorphism in cysteinyl leukotriene receptor 2 on chromosome 13q14 and atopic asthma. Pharmacogenetics 14: 683-690.
25. Hui, Y., G. Yang, H. Galczenski, D. J. Figueroa, C. P. Austin, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, and C. D. Funk. 2001. The murine cysteinyl leukotriene 2 (CysLT2) receptor: cDNA and genomic cloning, alternative splicing, and in vitro characterization. J. Biol. Chem. 276: 47489-47495.
26. DeLong, C. S., and W. L. Smith. 2005. An intronic enhancer regulates cyclooxygenase-1 gene expression. Biochem. Biophys. Res. Commun. 338: 53-61.
27. Fujii, M., H. Tanaka, and S. Abe. 2005. Interferon-γ up-regulates expression of cysteinyl leukotriene type 2 receptors on eosinophils in asthmatic patients. Chest 128: 3148-3155.
28. Uzonyi, B., K. Lotzer, S. Jahn, C. Kramer, M. Hildner, E. Bretschneider, D. Radke, M. Beer, R. Vollandt, J. F. Evans, et al. 2006. Cysteinyl leukotriene 2 . receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells. Proc. Natl. Acad. Sci. USA 103: 6326-6331.
29. Mellor, E. A., N. Frank, D. Soler, M. R. Hodge, J. M. Lora, K. F. Austen, and J. A. Boyce. 2003. Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: functional distinction from CysLT1R. Proc. Natl. Acad. Sci. USA 100: 11589-11593.
30. Khachigian, L. M. 2006. Early growth response-1 in cardiovascular pathobiology. Circ. Res. 98: 186-191.
31. Droin, N. M., M. J. Pinkoski, E. Dejardin, and D. R. Green. 2003. Egr family members regulate nonlymphoid expression of Fas ligand, TRAIL, and tumor necrosis factor during immune responses. Mol. Cell. Biol. 23: 7638-7647.
32. Wieland, G. D., N. Nehmann, D. Muller, H. Eibel, U. Siebenlist, J. Suhnel, P. F. Zipfel, and C. Skerka. 2005. Early growth response proteins EGR-4 and EGR-3 interact with immune inflammatory mediators NF-κB p50 and p65. J. Cell Sci. 118: 3203-3212.